- FDA-approved December 2024 for moderate-to-severe OSA in adults with obesity
- Coverage criteria typically require BMI ≥ 30 and AHI ≥ 15 on a recent sleep study
- Trials showed ~25 events/hour reduction in AHI at the highest dose
- Many plans that exclude weight-loss medications cover Zepbound under the OSA indication
Why the OSA approval changes coverage
Before December 2024, Zepbound was only labeled for chronic weight management — an indication many employer plans exclude entirely. The new OSA approval gives prescribers a second covered indication that bypasses anti-obesity drug exclusions on most commercial formularies.
If your initial Zepbound prior authorization was denied as a weight-loss medication, ask your prescriber whether you also meet OSA criteria. A documented AHI ≥ 15 and BMI ≥ 30 is often enough to flip a denial.
What the SURMOUNT-OSA trials showed
The two SURMOUNT-OSA trials (NEJM, 2024) studied adults with moderate-to-severe OSA and obesity over 52 weeks. Patients on tirzepatide saw apnea-hypopnea index reductions of ~25 events/hour at the highest dose, versus ~5 events/hour on placebo. Roughly 40–50% of trial participants reached an AHI < 5 (clinical resolution). Average body-weight loss was 18–20%.
Coverage criteria most plans require
Adult age (18+) with obesity (BMI ≥ 30 kg/m²).
Moderate-to-severe OSA defined as AHI ≥ 15 on a recent in-lab polysomnography or validated home sleep apnea test.
Continued use of, or documented intolerance to, positive airway pressure therapy (CPAP/APAP/BiPAP).
Prescription written by or in consultation with a sleep specialist, pulmonologist, or obesity medicine physician.
How to file the prior authorization
Submit the sleep-study report, BMI documentation, CPAP adherence data (or intolerance notes), and ICD-10 codes G47.33 (obstructive sleep apnea, adult) plus E66.01 (morbid obesity) or E66.9 (obesity). Most insurers approve within 5–14 business days when all four elements are present.
What if my plan still denies?
OSA denials are most often procedural — missing sleep study, missing BMI, wrong ICD-10. Request the specific denial reason in writing, then resubmit with the missing element. If denied on medical necessity grounds despite meeting label criteria, file a formal appeal citing the FDA label and the SURMOUNT-OSA evidence.
Frequently asked questions
Check your Zepbound OSA approval odds
Answer a few questions about your AHI, BMI, and plan — get a personalized approval-likelihood score and a tailored documentation checklist.
Educational guidance only — not medical or legal advice.